Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
ATP Ventures Partner is a biotechnology investment organization located in Jersey City, New Jersey. The firm specializes in creating and investing in drug development companies and partners with renowned research institutions. They focus on high-potential biotech assets and engage in global asset scouting.
ATP Ventures Partner invests in pre-seed, seed, Series A, and growth equity stages, primarily targeting biotech sectors such as anti-aging, women's health, mental health, metabolism/cardiovascular, and ophthalmology. They provide support in strategy, fundraising, and establishing partnerships to facilitate successful exits, including IPOs and mergers and acquisitions.
One notable portfolio company is Flatbird Tx, which operates within the therapeutic areas of interest identified by ATP Ventures Partner.
Email your deck to info@atpvent.com for consideration.
ATP Ventures Partner typically leads investment rounds, especially in the early stages of funding.
The firm is open to follow-on investments, particularly for companies that demonstrate significant growth potential and align with their strategic focus.
Specific fund size details are not disclosed, but the firm actively engages in multiple investment stages, indicating a substantial capital base.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.